Pressroom: Media Coverage

Showing 421 - 440 of 610 news items

2012

Breast Cancer Hot Topic: Clear Tumor Margins

Many women who have lumpectomies must have a re-operation in order to achieve cancer-free margins around the surgically removed tumor, but there is debate in the medical community as to what constitutes a clear margin. Breast Surgical Service Chief Monica Morrow suggested research could be better directed toward identifying factors that cause early-stage breast cancer to become invasive, which she believes is critical to tailoring treatment.

March 26, 2012
How Much Aspirin Is Too Much of a Good Thing?

Breast Cancer Medicine Service Chief Clifford Hudis commented on recent studies that suggest that daily aspirin use may reduce the risk of several cancers and stop the spread of tumors. He said that while the data with regard to breast cancer is interesting, it is not actionable.

March 26, 2012
How Collaboration Between IBM and Memorial Sloan Kettering Taps the Wisdom of Physicians

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton authored this post about the new MSKCC-IBM collaboration to develop a decision-support tool based upon IBM’s Watson computer. He said, “The human is never left out of the conversation. And that humanity—never before captured in guidelines or lists of therapeutic options—is what makes this project unique: It goes beyond mere knowledge, as important as that is, by entering the realm of human wisdom.”

March 23, 2012
IBM’s Watson to Help Memorial Sloan Kettering with Cancer

Memorial Sloan Kettering and IBM announced they will collaborate on the development of a powerful new tool built upon IBM’s Watson computer. Memorial Sloan Kettering will “teach” the computer to review case histories so oncologists located anywhere will have the ability to obtain detailed diagnostic and treatment options based on the latest research. Memorial Sloan Kettering President and CEO Craig Thompson said it has the potential to revolutionize the accessibility of information.

March 22, 2012
IBM Watson Hits Daily Double Fighting Cancer with Memorial Sloan Kettering

Thoracic Oncology Service Chief Mark Kris said the new MSKCC-IBM collaboration to develop a supercomputer to support oncologists is “like having a Memorial Sloan Kettering trained colleague for any doctor on earth.” Built upon IBM’s Watson computer, the new tool will combine Watson’s advanced analytics capabilities with Memorial Sloan Kettering’s clinical insights.

March 22, 2012
Could Graphic New Anti Smoking Ads Do More Harm?

Infectious disease specialist Kent Sepkowitz authored this essay about the CDC’s new campaign of graphic anti-smoking ads. He discussed the use of fear to promote a change in behavior and said, “The scarier the message, the stronger the effect.”

March 16, 2012
Leukemia Gene Mutations Linked to Survival Odds

Physician-scientist Ross Levine discussed his study that found that a mutation in the gene known as TET2 contributes to the development of some leukemias. The discovery provides a key insight into what first goes wrong in the development of many leukemias and shows that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets.

March 15, 2012
Finding Reliable Cancer Information Online

Integrative Medicine Service Chief Barrie Cassileth talked about the dangers of exploring treatment options online, especially herbal remedies touted as cancer therapies because many consumers don’t realize that these may interfere with chemotherapy and prescription medications. She suggested visiting Memorial Sloan Kettering’s About Herbs database, which provides evidence-based information on more than 250 herbs, botanicals, and supplements.

March 14, 2012
Advances in Bladder Cancer Treatment Around the Corner

Urologic surgeon Harry Herr talked about current treatment options for bladder cancer and the research under way to bring new treatments to patients.

March 14, 2012
Pursuing an Ethic of Service: Lung Cancer Researcher Noted for Drug Discovery, Charitable Works

In this profile piece, Thoracic Oncology Service Chief Mark Kris discussed his career, current research interests, and charitable work. He said, “I’ve heard people say that, if you choose the right profession or job, you’ll never have to work a day in your life, and I feel like that.”

March 13, 2012
Many with Cancer Pain Aren't on Strong Painkillers

Pain and Palliative Care Service Chief Paul Glare commented on a study that found that one in three older cancer patients are not taking opioids to treat their pain. Dr. Glare said that if patients feel their pain is not being addressed by their doctor, they should ask to see a pain specialist for treatment.

March 9, 2012
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug

Medical oncologist Jedd Wolchok discussed a unique single-patient study that demonstrates a rare phenomenon called the abscopal effect, in which radiation to just one tumor causes other tumors all over the body to regress. The patient studied took ipilimumab (Yervoy™), a drug that stimulates the immune system to fight cancer cells, but did not respond to the medicine until she got a radiation treatment.

March 8, 2012
New Treatment Successfully Targets Tumors

Medical oncologist Jedd Wolchok and his patient Valerie Esposito spoke about the rare medical phenomenon she experienced when local radiation to just one tumor caused other tumors in her body to shrink. Dr. Wolchok said, “We’re very excited about this result because we treated just one tumor with radiation therapy in this patient, and as a result, distant tumors regressed.”

March 7, 2012
Answers in Medicine Sometimes Lie in Luck

Infectious disease specialist Kent Sepkowitz authored this essay about doctors who believe in luck. He said that despite the endless evidence demonstrating its nonexistence, all doctors believe in luck because most of what happens to patients still falls well outside their understanding.

March 6, 2012
Meaning-Based Therapy May Aid Terminal Patient

Psychiatry Service Chief William Breitbart discussed his study that found that talk therapy sessions focused on spirituality and finding meaning improved quality of life and well-being in terminally ill cancer patients. Dr. Breitbart said, “What’s critical for cancer patients is for them to understand that even with advanced cancer, there is always the possibility for the experience of meaning, even in the last days of life.”

March 2, 2012
“Chemobrain” May Linger 20 Years after Breast Cancer Treatment

New research suggests that “chemobrain,” the name given to the mental fog and related memory problems that can occur during and after chemotherapy, may last for two decades after breast cancer treatment. Psychologist Tim Ahles said the new study is the first to illustrate that long-term breast cancer survivors still experience difficulty with their thought processes.

February 27, 2012
Report Affirms Lifesaving Role of Colonoscopy

A new study led by epidemiologist Ann Zauber and gastroenterologist Sidney Winawer found that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Although many people have assumed that colonoscopy must save lives because it is so often recommended, strong evidence has been lacking until now.

February 23, 2012
New Hospital Cuisine: Dishes Made to Order

Chemotherapy can dramatically affect a patient’s appetite, tastes, and diet. Executive Chef Pnina Peled talked about a growing trend among hospitals to revamp their kitchens and offer more-personalized menu items for patients with a variety of nutritional needs. Food and Nutrition Services Director Veronica McLymont was also quoted.

February 21, 2012
Clinical Trials Network Aims to Strengthen Cancer Immunotherapy Pipeline

Medical oncologist Jedd Wolchok spoke about a new initiative called the Cancer Immunotherapy Trials Network (CITN). Dr. Wolchok is one of 27 researchers chosen from the nation’s top cancer centers and universities to lead clinical trials to spur the development of cancer treatments that work by revving up the immune system’s response to tumors.

February 21, 2012
What's the Cure in the Race against Breast Cancer?

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed about prevention and treatment innovations for breast cancer patients. He said, “There are a lot of very exciting things that are moving forward, and it’s all based on a new understanding of the biology of cancer.”

NPR
February 19, 2012